The global translational regenerative medicine market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in the field of regenerative medicine. Stem cell therapy segment accounted for the largest share in the global translational regenerative medicine market in 2018 and is expected to continue its dominance throughout the forecast period. Tissue engineering segment accounted for a significant share in this market due to its ability to regenerate damaged tissues and organs with minimal side effects. Gene therapy segment is also expected to grow at a significant rate during the forecast period due to its ability to treat genetic disorders such as hemophilia A & B, cystic fibrosis, sickle cell anemia etc, which are not curable by other therapies available today. .
Some Of The Growth Factors Of This Market:
- Regenerative Medicine Market Growth Factors:.
Industry Growth Insights published a new data on “Translational Regenerative Medicine Market”. The research report is titled “Translational Regenerative Medicine Market research by Types (Stem Cell Therapy, Tissue Engineering, Gene Therapy), By Applications (Tissue Engineering Therapy, Wound Healing, Cartilage Repair, Other), By Players/Companies Athersys, Avita Medical, AxoGen, MEDIPOST, NuVasive, Astellas Pharma, Organogenesis Holdings, Osiris Therapeutics, Pharmicell, Regenerys, Takeda Pharmaceutical, uniQure, Vericel”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Translational Regenerative Medicine Market Research Report
By Type
Stem Cell Therapy, Tissue Engineering, Gene Therapy
By Application
Tissue Engineering Therapy, Wound Healing, Cartilage Repair, Other
By Companies
Athersys, Avita Medical, AxoGen, MEDIPOST, NuVasive, Astellas Pharma, Organogenesis Holdings, Osiris Therapeutics, Pharmicell, Regenerys, Takeda Pharmaceutical, uniQure, Vericel
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Translational Regenerative Medicine Market Report Segments:
The global Translational Regenerative Medicine market is segmented on the basis of:
Types
Stem Cell Therapy, Tissue Engineering, Gene Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tissue Engineering Therapy, Wound Healing, Cartilage Repair, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Athersys
- Avita Medical
- AxoGen
- MEDIPOST
- NuVasive
- Astellas Pharma
- Organogenesis Holdings
- Osiris Therapeutics
- Pharmicell
- Regenerys
- Takeda Pharmaceutical
- uniQure
- Vericel
Highlights of The Translational Regenerative Medicine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Stem Cell Therapy
- Tissue Engineering
- Gene Therapy
- By Application:
- Tissue Engineering Therapy
- Wound Healing
- Cartilage Repair
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Translational Regenerative Medicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Translational Regenerative Medicine is a field of medicine that uses regenerative therapies to help patients with serious diseases. These therapies can help replace or repair damaged tissue, organs, and cells.
Some of the key players operating in the translational regenerative medicine market are Athersys, Avita Medical, AxoGen, MEDIPOST, NuVasive, Astellas Pharma, Organogenesis Holdings, Osiris Therapeutics, Pharmicell, Regenerys, Takeda Pharmaceutical, uniQure, Vericel.
The translational regenerative medicine market is expected to grow at a compound annual growth rate of 12.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Translational Regenerative Medicine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Translational Regenerative Medicine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Translational Regenerative Medicine Market - Supply Chain
4.5. Global Translational Regenerative Medicine Market Forecast
4.5.1. Translational Regenerative Medicine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Translational Regenerative Medicine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Translational Regenerative Medicine Market Absolute $ Opportunity
5. Global Translational Regenerative Medicine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Translational Regenerative Medicine Market Size and Volume Forecast by Type
5.3.1. Stem Cell Therapy
5.3.2. Tissue Engineering
5.3.3. Gene Therapy
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Translational Regenerative Medicine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Translational Regenerative Medicine Market Size and Volume Forecast by Application
6.3.1. Tissue Engineering Therapy
6.3.2. Wound Healing
6.3.3. Cartilage Repair
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Translational Regenerative Medicine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Translational Regenerative Medicine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Translational Regenerative Medicine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Translational Regenerative Medicine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Translational Regenerative Medicine Demand Share Forecast, 2019-2026
9. North America Translational Regenerative Medicine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Translational Regenerative Medicine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Translational Regenerative Medicine Market Size and Volume Forecast by Application
9.4.1. Tissue Engineering Therapy
9.4.2. Wound Healing
9.4.3. Cartilage Repair
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Translational Regenerative Medicine Market Size and Volume Forecast by Type
9.7.1. Stem Cell Therapy
9.7.2. Tissue Engineering
9.7.3. Gene Therapy
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Translational Regenerative Medicine Demand Share Forecast, 2019-2026
10. Latin America Translational Regenerative Medicine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Translational Regenerative Medicine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Translational Regenerative Medicine Market Size and Volume Forecast by Application
10.4.1. Tissue Engineering Therapy
10.4.2. Wound Healing
10.4.3. Cartilage Repair
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Translational Regenerative Medicine Market Size and Volume Forecast by Type
10.7.1. Stem Cell Therapy
10.7.2. Tissue Engineering
10.7.3. Gene Therapy
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Translational Regenerative Medicine Demand Share Forecast, 2019-2026
11. Europe Translational Regenerative Medicine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Translational Regenerative Medicine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Translational Regenerative Medicine Market Size and Volume Forecast by Application
11.4.1. Tissue Engineering Therapy
11.4.2. Wound Healing
11.4.3. Cartilage Repair
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Translational Regenerative Medicine Market Size and Volume Forecast by Type
11.7.1. Stem Cell Therapy
11.7.2. Tissue Engineering
11.7.3. Gene Therapy
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Translational Regenerative Medicine Demand Share, 2019-2026
12. Asia Pacific Translational Regenerative Medicine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Translational Regenerative Medicine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Translational Regenerative Medicine Market Size and Volume Forecast by Application
12.4.1. Tissue Engineering Therapy
12.4.2. Wound Healing
12.4.3. Cartilage Repair
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Translational Regenerative Medicine Market Size and Volume Forecast by Type
12.7.1. Stem Cell Therapy
12.7.2. Tissue Engineering
12.7.3. Gene Therapy
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Translational Regenerative Medicine Demand Share, 2019-2026
13. Middle East & Africa Translational Regenerative Medicine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Translational Regenerative Medicine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Translational Regenerative Medicine Market Size and Volume Forecast by Application
13.4.1. Tissue Engineering Therapy
13.4.2. Wound Healing
13.4.3. Cartilage Repair
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Translational Regenerative Medicine Market Size and Volume Forecast by Type
13.7.1. Stem Cell Therapy
13.7.2. Tissue Engineering
13.7.3. Gene Therapy
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Translational Regenerative Medicine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Translational Regenerative Medicine Market: Market Share Analysis
14.2. Translational Regenerative Medicine Distributors and Customers
14.3. Translational Regenerative Medicine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Athersys
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Avita Medical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. AxoGen
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. MEDIPOST
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. NuVasive
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Astellas Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Organogenesis Holdings
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Osiris Therapeutics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Pharmicell
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Regenerys
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Takeda Pharmaceutical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. uniQure
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Vericel
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook